MaRS Impact Health: Canada’s premier health venture summit returns on June 12 & 13
Showcasing innovations in digital health, medical devices and biotech with industry leading speakers, including Geoffrey von Maltzahn, general partner at Flagship Pioneering and Alán Aspuru-Guzik, director of the Acceleration Consortium.
TORONTO, May 23, 2024 — Today, MaRS announced the program and partners for its annual health innovation event, MaRS Impact Health. The two-day summit returns on June 12 and 13, featuring some of the world’s top leaders in healthcare and more than 500 attendees — industry experts, investors and innovators working across digital health, medical devices and biotech.
Impact Health has partnered with dozens of health stakeholders, including: AdvaMed, Alberta Innovates, Altis Labs, API, AstraZeneca, Bayer, Blakes, District 3 Innovation, FACIT, Johnson & Johnson, MaRS IAF, Megalab, Mintz, OICR, Ontario Brain Institute, Shoppers Drug Mart, Stem Cell Network, Takeda, Thermo Fisher, TIAP, TRBOT, TUV SUD, UHN KITE and Velocity. This year’s media partners include: BetaKit, Canadian Healthcare Technology Magazine, The Peak and Toronto Star.
“MaRS Impact Health brings North America’s health innovation ecosystem together to discuss our most complex health venture challenges and celebrate its most promising opportunities,” said Amol Deshpande, senior director, health sciences, MaRS. “We are thrilled to announce our exceptional lineup of partners and speakers for 2024.”
MaRS Impact Health will take place at the MaRS Centre in downtown Toronto. It will bring together more than 100 health experts to the stage, including Jonathan Norris, managing director of innovation banking at HSBC; Nisha Marathe, investment director at Roche Venture Fund; Geoffrey von Maltzahn, general partner at Flagship Pioneering; Heather McDonald, vice president of market access and pricing at AstraZeneca; Jefferson Tea, vice president, medical & scientific affairs at Takeda Canada Inc; and Alán Aspuru-Guzik, director of the Acceleration Consortium at the University of Toronto. For a full list of speakers visit: https://impacthealth.marsdd.com/speakers
MaRS Impact Health’s programming falls into three tracks:
- Biotech and Life Sciences: Research, methodologies and technologies accelerating the discovery and development of safe, novel and effective medicines and treatments.
- Digital Health: Groundbreaking technologies and platforms helping healthcare professionals provide remote care, monitor patients, make better-informed decisions, as well as provide more safe and effective treatments.
- Medical Devices: From implants to instruments, we explore innovative devices improving accuracy in diagnostics, monitoring and treatment.
Tickets are $499 until June 4 and include:
- Insights from 100+ extraordinary speakers: world-leading scientists, entrepreneurs, investors and industry experts
- More than 15 keynote, fireside and panel discussions as well as tech trend presentations and pitches during the two-day program — the latest innovations in healthcare, biotech, life sciences, digital health and medical devices
- Curated networking between startups, investors and corporate partners
- Access to hundreds of health innovation experts — entrepreneurs, investors, policy makers, clinicians, industry professionals and media — all uniquely positioned to help ventures of all stages bring their innovations to market
- Startup pitch sessions, expos and showcases from 65+ startup ventures
- A closing night reception celebrating health founders and an opportunity to connect and mingle with fellow attendees and speakers
About MaRS Impact Health
MaRS Impact Health features the most promising companies and discoveries solving today’s biggest health challenges in digital health, devices and biotech. Connect with the brilliant minds improving healthcare on a global scale: entrepreneurs, investors, academics, clinicians and policy-makers.
Learn more and register for MaRS Impact Health at https://impacthealth.marsdd.com
Media Contact: